WallStreetZenWallStreetZen

NASDAQ: CADL
Candel Therapeutics Inc Stock Ownership - Who owns Candel Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Candel Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Paul Peter TakChief Executive Officer2025-03-19400$9.00
$3.60kSell
Paul Peter TakChief Executive Officer2025-03-1825,772$8.77
$226.02kSell
William Garrett NicholsChief Medical Officer2025-03-1813,905$1.29
$17.94kBuy
William Garrett NicholsChief Medical Officer2025-03-1845,316$8.76
$397.01kSell
Francesca BaroneChief Scientific Officer2025-03-1818,000$1.55
$27.90kBuy
Francesca BaroneChief Scientific Officer2025-03-1832,146$8.76
$281.66kSell
William Garrett NicholsChief Medical Officer2025-03-184,584$3.75
$17.19kBuy
Seshu TyagarajanChief Technology Officer2025-03-1731,278$8.82
$275.93kSell
Seshu TyagarajanChief Technology Officer2025-03-1720,000$1.29
$25.80kBuy
Seshu TyagarajanChief Technology Officer2025-03-1731,278$8.82
$275.93kSell

1 of 9

CADL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when CADL insiders and whales buy or sell their stock.

CADL Shareholders

What type of owners hold Candel Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Estuardo Aguilarcordova15.15%7,156,946$35.57MInsider
Paul B. Manning8.74%4,127,158$20.51MInsider
Fmr LLC8.31%3,923,599$19.50MInstitution
Laura K. Aguilar6.45%3,046,940$15.14MInsider
Baker Bros Advisors LP6.31%2,981,983$14.82MInstitution
Acorn Capital Advisors LLC4.11%1,939,644$9.64MInstitution
Braidwell LP3.39%1,600,000$7.95MInstitution
Vanguard Group Inc2.84%1,339,150$6.66MInstitution
Blackrock Inc2.51%1,183,947$5.88MInstitution
Portolan Capital Management LLC1.60%753,745$3.75MInstitution

1 of 3

CADL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
CADL37.95%33.37%Net SellingNet Selling
LSB0.20%0.00%
PLX3.18%96.82%
OABI52.05%26.35%Net BuyingNet Buying
CDTX34.46%65.54%Net BuyingNet Selling
View Top Biotech Stocks

Candel Therapeutics Stock Ownership FAQ

Who owns Candel Therapeutics?

Candel Therapeutics (NASDAQ: CADL) is owned by 37.95% institutional shareholders, 33.37% Candel Therapeutics insiders, and 28.67% retail investors. Estuardo Aguilarcordova is the largest individual Candel Therapeutics shareholder, owning 7.16M shares representing 15.15% of the company. Estuardo Aguilarcordova's Candel Therapeutics shares are currently valued at $34.64M.

If you're new to stock investing, here's how to buy Candel Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.